v3.26.1
Consolidated Statement of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Statement of Cash Flows [Abstract]    
 Net loss $ (25,234,834) $ (23,756,551)
(Income) loss from discontinued operations 885,564 1,823,413
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 9,284 401,602
Amortization of debt discount 2,450,178 3,677,143
ROU assets, net (24,093) 5,900
Loss from intangible impairment 4,324,064
Non-cash share-based compensation 8,510,946 2,350,482
Change in FV of derivative liability 20,406
Loss on extinguishment of debt 5,560,482
Changes in working capital items:      
Accounts receivable, net   176,244 334,579
Inventory, net     285,566 595,649
Prepaid expenses and other current assets 205,287 (53,542)
Deposits       26,188 524
Accounts payable and accrued expenses 728,690 640,806
Accrued interest payable   1,580,074 2,352,787
Liability to issue shares  
Net cash used in operating activities - continuing operations (4,820,018) (7,303,145)
Cash flows from investing activities - continuing operations    
Capital expenditures  
Net cash used in investing activities - continuing operations
Cash flows from financing activities - continuing operations:    
Cash advance (repayment) from related party 9,000
Proceeds from issuance of debt 4,384,445 9,545,300
Proceeds from sale of preferred stock 1,300,000
Principal repayment of debt   (580,308) (2,009,541)
Net cash provided by financing activities - continuing operations 5,104,137 7,544,759
Cash flows from discontinued operations      
Operating cash flows   30,879 (492,756)
Investing cash flows  
Financing cash flows  
Net cash provided by (used in) discontinued operations 30,879 (492,756)
Net cash effect of exchange rates on cash (47,352) 97,763
Net change in cash and cash equivalents   267,646 (153,379)
Cash and cash equivalents, beginning of year 13,789 167,168
Cash and cash equivalents, end of period 281,435 13,789
Supplemental Disclosure of Cash Flow Information:    
 Cash paid for Interest 132,863 795,022
 Supplemental Disclosure of Non-Cash Investing and Financing Activities    
 Notes payable and accrued interest converted to Common Stock (944,685 shares in 2025 & 171,536 shares in 2024,) 2,502,246 1,769,656
 Non-cash debt discount in the form of issuance of equity instruments in conjunction with convertible notes 747,558 2,815,743
 Series-B Convertible Preferred Stock Issued 126,710 shares exchanged for  notes payable and accrued interest $ 12,670,435